Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from AVEO Pharmaceuticals

India bans drugs blamed for opioid crisis in West Africa

Aveo Pharmaceuticals is accused of illegally exporting banned combination of tapentadol and carisoprodol to Nigeria, Ghana and Ivory Coast

The Independent UK · Feb 24, 2025

Looking Into AVEO Pharmaceuticals's Return On Capital Employed

AVEO Pharmaceuticals (NASDAQ:AVEO) brought in sales totaling $20.92 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 40.58%, resulting in a loss of $10.20 million.

Benzinga · May 26, 2022

Recap: AVEO Pharmaceuticals Q1 Earnings

AVEO Pharmaceuticals (NASDAQ:AVEO) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 5, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Preview: AVEO Pharmaceuticals

AVEO Pharmaceuticals (NASDAQ:AVEO) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that AVEO Pharmaceuticals will report an earnings per share (EPS) of $-0.25.

Benzinga · May 4, 2022

AVEO Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know

AVEO Pharmaceuticals (NASDAQ:AVEO) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results.

Benzinga · May 4, 2022

AVEO Pharmaceuticals's Return On Capital Employed Insights

According to Benzinga Pro data, during Q4, AVEO Pharmaceuticals (NASDAQ:AVEO) posted sales of $17.65 million. Earnings were up 30.03%, but AVEO Pharmaceuticals still reported an overall loss of $7.25 million.

Benzinga · Mar 15, 2022

Earnings Preview For AVEO Pharmaceuticals

AVEO Pharmaceuticals (NASDAQ:AVEO) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement. Analysts estimate that AVEO Pharmaceuticals will report an earnings per share (EPS) of $-0.29.

Benzinga · Mar 11, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

Organisations

Nasdaq

22,873 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.